Search

Stephen Gucker

Examiner (ID: 445)

Most Active Art Unit
1649
Art Unit(s)
1649, 1647, 1812, 1818, 1646, 1645
Total Applications
799
Issued Applications
370
Pending Applications
114
Abandoned Applications
315

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5474291 [patent_doc_number] => 20090247457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'NEUROTROPHIC COMPONENTS OF THE ADNF I COMPLEX' [patent_app_type] => utility [patent_app_number] => 12/197915 [patent_app_country] => US [patent_app_date] => 2008-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 26874 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247457.pdf [firstpage_image] =>[orig_patent_app_number] => 12197915 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/197915
NEUROTROPHIC COMPONENTS OF THE ADNF I COMPLEX Aug 24, 2008 Abandoned
Array ( [id] => 5264358 [patent_doc_number] => 20090117043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Antibodies That Specifically Bind to Neurokinin B' [patent_app_type] => utility [patent_app_number] => 12/191875 [patent_app_country] => US [patent_app_date] => 2008-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51026 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20090117043.pdf [firstpage_image] =>[orig_patent_app_number] => 12191875 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/191875
Antibodies That Specifically Bind to Neurokinin B Aug 13, 2008 Abandoned
Array ( [id] => 4618766 [patent_doc_number] => 07998480 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Human BNP immunospecific antibodies' [patent_app_type] => utility [patent_app_number] => 12/189232 [patent_app_country] => US [patent_app_date] => 2008-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 35 [patent_no_of_words] => 30406 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/998/07998480.pdf [firstpage_image] =>[orig_patent_app_number] => 12189232 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/189232
Human BNP immunospecific antibodies Aug 10, 2008 Issued
Array ( [id] => 6443891 [patent_doc_number] => 20100144616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Neuroprotective methods and reagents' [patent_app_type] => utility [patent_app_number] => 12/220865 [patent_app_country] => US [patent_app_date] => 2008-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 26127 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144616.pdf [firstpage_image] =>[orig_patent_app_number] => 12220865 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/220865
Neuroprotective methods and reagents Jul 27, 2008 Abandoned
Array ( [id] => 6422803 [patent_doc_number] => 20100167937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Multiple forms of Alzheimer\'s disease based on differences in concentrations of protein biomarkers in blood serum' [patent_app_type] => utility [patent_app_number] => 12/217885 [patent_app_country] => US [patent_app_date] => 2008-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 33886 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20100167937.pdf [firstpage_image] =>[orig_patent_app_number] => 12217885 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/217885
Multiple forms of Alzheimer's disease based on differences in concentrations of protein biomarkers in blood serum Jul 7, 2008 Abandoned
Array ( [id] => 210538 [patent_doc_number] => 07625864 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-01 [patent_title] => 'Methods and compositions for treating ocular disorders' [patent_app_type] => utility [patent_app_number] => 12/164938 [patent_app_country] => US [patent_app_date] => 2008-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3904 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/625/07625864.pdf [firstpage_image] =>[orig_patent_app_number] => 12164938 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/164938
Methods and compositions for treating ocular disorders Jun 29, 2008 Issued
Array ( [id] => 6395449 [patent_doc_number] => 20100178293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-15 [patent_title] => 'USE OF ANTIBODIES AGAINST THE CD52 ANTIGEN FOR THE TREATMENT OF NEUROLOGICAL DISORDERS, PARTICULARLY TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY AND ALZHEIMER\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 12/665401 [patent_app_country] => US [patent_app_date] => 2008-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2233 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20100178293.pdf [firstpage_image] =>[orig_patent_app_number] => 12665401 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/665401
USE OF ANTIBODIES AGAINST THE CD52 ANTIGEN FOR THE TREATMENT OF NEUROLOGICAL DISORDERS, PARTICULARLY TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY AND ALZHEIMER'S DISEASE Jun 9, 2008 Abandoned
Array ( [id] => 4628909 [patent_doc_number] => 08007791 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Prevention and treatment of complement-associated eye conditions' [patent_app_type] => utility [patent_app_number] => 12/154466 [patent_app_country] => US [patent_app_date] => 2008-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18554 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/007/08007791.pdf [firstpage_image] =>[orig_patent_app_number] => 12154466 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/154466
Prevention and treatment of complement-associated eye conditions May 21, 2008 Issued
Array ( [id] => 6420254 [patent_doc_number] => 20100150924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'REGULATION OF MYELINATION BY NECTIN-LIKE (NECL) MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/600833 [patent_app_country] => US [patent_app_date] => 2008-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 28083 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20100150924.pdf [firstpage_image] =>[orig_patent_app_number] => 12600833 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/600833
REGULATION OF MYELINATION BY NECTIN-LIKE (NECL) MOLECULES May 21, 2008 Abandoned
Array ( [id] => 111881 [patent_doc_number] => 07718605 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-18 [patent_title] => 'Compounds for intracellular delivery of therapeutic moieties to nerve cells' [patent_app_type] => utility [patent_app_number] => 12/116886 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6127 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/718/07718605.pdf [firstpage_image] =>[orig_patent_app_number] => 12116886 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/116886
Compounds for intracellular delivery of therapeutic moieties to nerve cells May 6, 2008 Issued
Array ( [id] => 6245635 [patent_doc_number] => 20100136002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'METHODS FOR TREATING AND PREVENTING MULTIPLE SCLEROSIS' [patent_app_type] => utility [patent_app_number] => 12/598525 [patent_app_country] => US [patent_app_date] => 2008-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16472 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136002.pdf [firstpage_image] =>[orig_patent_app_number] => 12598525 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/598525
Methods for treating and preventing multiple sclerosis Apr 30, 2008 Issued
Array ( [id] => 4675639 [patent_doc_number] => 20080213268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'NEUROPILIN ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/107544 [patent_app_country] => US [patent_app_date] => 2008-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 32654 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213268.pdf [firstpage_image] =>[orig_patent_app_number] => 12107544 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/107544
Neuropilin antagonists Apr 21, 2008 Issued
Array ( [id] => 6265011 [patent_doc_number] => 20100297678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'BIOMARKERS FOR MULTIPLE SCLEROSIS' [patent_app_type] => utility [patent_app_number] => 12/595597 [patent_app_country] => US [patent_app_date] => 2008-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10537 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297678.pdf [firstpage_image] =>[orig_patent_app_number] => 12595597 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/595597
Biomarkers for multiple sclerosis Apr 13, 2008 Issued
Array ( [id] => 6423802 [patent_doc_number] => 20100168016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'DIAGNOSIS AND TREATMENT OF DISEASES CAUSED BY MISFOLDED PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/593988 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 36628 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168016.pdf [firstpage_image] =>[orig_patent_app_number] => 12593988 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/593988
DIAGNOSIS AND TREATMENT OF DISEASES CAUSED BY MISFOLDED PROTEINS Apr 10, 2008 Abandoned
Array ( [id] => 4719338 [patent_doc_number] => 20080241860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'METHODS AND APPARATUS TO RECOGNIZE NERVE INJURIES' [patent_app_type] => utility [patent_app_number] => 12/101662 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4732 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241860.pdf [firstpage_image] =>[orig_patent_app_number] => 12101662 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/101662
METHODS AND APPARATUS TO RECOGNIZE NERVE INJURIES Apr 10, 2008 Abandoned
Array ( [id] => 4845475 [patent_doc_number] => 20080181883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Purified Antigen for Alzheimer\'s Disease and Methods of Obtaining and Using Same' [patent_app_type] => utility [patent_app_number] => 12/060350 [patent_app_country] => US [patent_app_date] => 2008-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14402 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20080181883.pdf [firstpage_image] =>[orig_patent_app_number] => 12060350 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/060350
Purified Antigen for Alzheimer's Disease and Methods of Obtaining and Using Same Mar 31, 2008 Abandoned
Array ( [id] => 4720067 [patent_doc_number] => 20080242590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'New Method 706' [patent_app_type] => utility [patent_app_number] => 12/057464 [patent_app_country] => US [patent_app_date] => 2008-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21455 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242590.pdf [firstpage_image] =>[orig_patent_app_number] => 12057464 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/057464
New Method 706 Mar 27, 2008 Abandoned
Array ( [id] => 4710669 [patent_doc_number] => 20080299195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'USE OF RANOLAZINE FOR ELEVATED BRAIN-TYPE NATRIURETIC PEPTIDE' [patent_app_type] => utility [patent_app_number] => 12/054334 [patent_app_country] => US [patent_app_date] => 2008-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5970 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299195.pdf [firstpage_image] =>[orig_patent_app_number] => 12054334 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/054334
USE OF RANOLAZINE FOR ELEVATED BRAIN-TYPE NATRIURETIC PEPTIDE Mar 23, 2008 Abandoned
Array ( [id] => 4740543 [patent_doc_number] => 20080234196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Treatment and prevention of vascular dementia' [patent_app_type] => utility [patent_app_number] => 12/072914 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 21421 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234196.pdf [firstpage_image] =>[orig_patent_app_number] => 12072914 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/072914
Treatment and prevention of vascular dementia Feb 27, 2008 Issued
Array ( [id] => 4728530 [patent_doc_number] => 20080208074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Methods and Systems for Characterizing and Generating a Patient-Specific Seizure Advisory System' [patent_app_type] => utility [patent_app_number] => 12/035335 [patent_app_country] => US [patent_app_date] => 2008-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 20390 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20080208074.pdf [firstpage_image] =>[orig_patent_app_number] => 12035335 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/035335
Methods and Systems for Characterizing and Generating a Patient-Specific Seizure Advisory System Feb 20, 2008 Abandoned
Menu